Press Releases
EMC Szpitale, Poland, brings access to innovative treatments to its patients by joining Clinerion’s Patient Network Explorer platform
EMC Szpitale augments Clinerion’s patient coverage in Poland by joining the Patient Network Explorer platform. Patients at the hospital group will gain greater access to clinical trials, and actively support in accelerating the successful launch of innovative medical treatments....
Press Releases
InSyBio Suite V2.5 has been launched and includes for the first time a complete pipeline for the analysis of RNA-sequencing data
The new version of InSyBio Suite enables the fast and accurate discovery of transcriptomics predictive biomarkers. The newly introduced pipeline in InSyBio ncRNAseq tool offers efficient, user friendly and secure pre-processing of RNA-sequencing data...
Press Releases
Codexis Announces CodeEvolver Technology Transfer and License Agreement with Global Pharmaceutical Leader
Codexis, Inc , a leading protein engineering company, announces the signing of a CodeEvolver® platform agreement with Novartis. Under the terms of the agreement, Codexis has granted a non-exclusive license to its proprietary CodeEvolver® protein engineering...
Press Releases
CPhI expert forecasts ‘huge growth in Middle East manufacturing with Europe a medium-term target’
CPhI Middle East & Africa (CPhI MEA) expert Madhukar Tanna, Chief Executive Officer of Pharmax, a United Arab Emirates (UAE) based branded generic manufacturer, says favourable conditions in the UAE are resulting in a boom of pharmaceutical manufacturing throughout...
Press Releases
Inpharamo will facilitate the entry of Clinerion into the Mexican clinical research market
Semicrol will facilitate the entry of Clinerion into Mexico through its subsidiary Inpharamo. Inpharamo’s network of contacts will serve as the gateway for the Swiss company into the country. Ian Rentsch, CEO of Clinerion, and Ricardo...
Press Releases
Recipharm launches Recipharm Inhalation SolutionsTM as its end-to-end offering for inhalation products
Recipharm, the contract development and manufacturing organisation (CDMO), has launched its end-to-end inhalation offering to provide customers with a fully integrated service from early stage development through to commercial manufacturing. Recipharm Inhalation Solutionsâ„¢, which launched at...
Press Releases
AstraZeneca starts artificial intelligence collaboration to accelerate drug discovery
AstraZeneca and Benevolent AI began a long-term collaboration to use artificial intelligence (AI) and machine learning for the discovery and development of new treatments for chronic kidney disease (CKD) and idiopathic pulmonary fibrosis (IPF). Scientists from...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read